1 |
Picker LJ, Lifson JD, Gale M Jr, Hansen SG, Früh K. Programming cytomegalovirus as an HIV vaccine. Trends Immunol 2023:S1471-4906(23)00026-1. [PMID: 36894436 DOI: 10.1016/j.it.2023.02.001] [Reference Citation Analysis]
|
2 |
Brochu H, Wang R, Tollison T, Pyo CW, Thomas A, Tseng E, Law L, Picker LJ, Gale M Jr, Geraghty DE, Peng X. Alternative splicing and genetic variation of mhc-e: implications for rhesus cytomegalovirus-based vaccines. Commun Biol 2022;5:1387. [PMID: 36536032 DOI: 10.1038/s42003-022-04344-2] [Reference Citation Analysis]
|
3 |
Hanke T. New vector and vaccine platforms: mRNA, DNA, viral vectors. Current Opinion in HIV and AIDS 2022;17:338-344. [DOI: 10.1097/coh.0000000000000763] [Reference Citation Analysis]
|
4 |
Obuku AE, Sharma A, Rukundo A, Odong M, Auma B, Serwanga J, Nkangi R, Okello J, Nakitto Z, Joloba M, Pantaleo G, Kaleebu P, Sekaly R. Impaired HIV-specific T-cell responses in HIV andS. mansonicoinfected Ugandans.. [DOI: 10.1101/2022.11.01.514652] [Reference Citation Analysis]
|
5 |
Malouli D, Gilbride RM, Wu HL, Hwang JM, Maier N, Hughes CM, Newhouse D, Morrow D, Ventura AB, Law L, Tisoncik-Go J, Whitmore L, Smith E, Golez I, Chang J, Reed JS, Waytashek C, Weber W, Taher H, Uebelhoer LS, Womack JL, McArdle MR, Gao J, Papen CR, Lifson JD, Burwitz BJ, Axthelm MK, Smedley J, Früh K, Gale M Jr, Picker LJ, Hansen SG, Sacha JB. Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species. Cell Host Microbe 2022;30:1207-1218.e7. [PMID: 35981532 DOI: 10.1016/j.chom.2022.07.013] [Reference Citation Analysis]
|
6 |
Hansen SG, Hancock MH, Malouli D, Marshall EE, Hughes CM, Randall KT, Morrow D, Ford JC, Gilbride RM, Selseth AN, Trethewy RE, Bishop LM, Oswald K, Shoemaker R, Berkemeier B, Bosche WJ, Hull M, Silipino L, Nekorchuk M, Busman-Sahay K, Estes JD, Axthelm MK, Smedley J, Shao D, Edlefsen PT, Lifson JD, Früh K, Nelson JA, Picker LJ. Myeloid cell tropism enables MHC-E-restricted CD8(+) T cell priming and vaccine efficacy by the RhCMV/SIV vaccine. Sci Immunol 2022;7:eabn9301. [PMID: 35714200 DOI: 10.1126/sciimmunol.abn9301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
7 |
Izmirly AM, Pelletier A, Connors J, Taramangalam B, Alturki SO, Gordon EA, Alturki SO, Mell JC, Swaminathan G, Karthik V, Kutzler MA, Kallas EG, Sekaly R, Haddad EK. Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine. PLoS Pathog 2022;18:e1009903. [DOI: 10.1371/journal.ppat.1009903] [Reference Citation Analysis]
|
8 |
Conlon K, Watson DC, Waldmann TA, Valentin A, Bergamaschi C, Felber BK, Peer CJ, Figg WD, Potter EL, Roederer M, McNeel DG, Thompson JA, Gupta S, Leidner R, Wang-Gillam A, Parikh NS, Long D, Kurtulus S, Ho Lee L, Chowdhury NR, Bender F, Pavlakis GN. Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors. J Immunother Cancer 2021;9:e003388. [PMID: 34799399 DOI: 10.1136/jitc-2021-003388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
9 |
Izmirly AM, Pelletier A, Connors J, Taramangalam B, Alturki SO, Gordon EA, Alturki SO, Mell JC, Swaminathan G, Karthik V, Kutzler MA, Kallas EG, Sekaly R, Haddad EK. Pre-vaccination Frequency of Circulatory Tfh is associated with Robust Immune Response to TV003 Dengue Vaccine.. [DOI: 10.1101/2021.08.19.456926] [Reference Citation Analysis]
|
10 |
D'Souza MP, Palin AC, Calder T, Golding H, Kleinstein SH, Milliken EL, O'Connor D, Tomaras G, Warren J, Boggiano C. Mind the gap from research laboratory to clinic: Challenges and opportunities for next-generation assays in human diseases. Vaccine 2021;39:5233-9. [PMID: 34366145 DOI: 10.1016/j.vaccine.2021.07.071] [Reference Citation Analysis]
|
11 |
Méndez-Lagares G, Chin N, Chang WLW, Lee J, Rosás-Umbert M, Kieu HT, Merriam D, Lu W, Kim S, Adamson L, Brander C, Luciw PA, Barry PA, Hartigan-O'Connor DJ. Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function. J Clin Invest 2021;131:148542. [PMID: 34153005 DOI: 10.1172/JCI148542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|